Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEFLUNOMIDE Cause C-reactive protein increased? 3,574 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 3,574 reports of C-reactive protein increased have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 6.3% of all adverse event reports for LEFLUNOMIDE.

3,574
Reports of C-reactive protein increased with LEFLUNOMIDE
6.3%
of all LEFLUNOMIDE reports
1,053
Deaths
1,916
Hospitalizations

How Dangerous Is C-reactive protein increased From LEFLUNOMIDE?

Of the 3,574 reports, 1,053 (29.5%) resulted in death, 1,916 (53.6%) required hospitalization, and 1,055 (29.5%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEFLUNOMIDE. However, 3,574 reports have been filed with the FAERS database.

What Other Side Effects Does LEFLUNOMIDE Cause?

Drug ineffective (31,396) Rheumatoid arthritis (20,886) Pain (15,594) Drug intolerance (14,142) Joint swelling (13,026) Fatigue (11,959) Arthralgia (11,880) Rash (11,239) Contraindicated product administered (11,206) Abdominal discomfort (10,333)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096) PREDNISONE (2,363)

Which LEFLUNOMIDE Alternatives Have Lower C-reactive protein increased Risk?

LEFLUNOMIDE vs LEMBOREXANT LEFLUNOMIDE vs LENACAPAVIR LEFLUNOMIDE vs LENALIDOMIDE LEFLUNOMIDE vs LENIOLISIB LEFLUNOMIDE vs LENOGRASTIM

Related Pages

LEFLUNOMIDE Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased LEFLUNOMIDE Demographics